Cargando…
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
Drug resistance limits the achievement of persistent cures for the treatment of melanoma, in spite of the efficacy of the available drugs. The aim of the present study was to explore the involvement of lipid metabolism in melanoma resistance and assess the effects of its targeting in cellular models...
Autores principales: | Vergani, Elisabetta, Beretta, Giovanni L., Aloisi, Mariachiara, Costantino, Matteo, Corno, Cristina, Frigerio, Simona, Tinelli, Stella, Dugo, Matteo, Accattatis, Felice Maria, Granata, Agnese, Arnaboldi, Lorenzo, Rodolfo, Monica, Perego, Paola, Gatti, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326082/ https://www.ncbi.nlm.nih.gov/pubmed/35912092 http://dx.doi.org/10.3389/fcell.2022.927118 |
Ejemplares similares
-
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations
por: Stamatakos, Serena, et al.
Publicado: (2021) -
Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells
por: Guzzetti, Carlotta, et al.
Publicado: (2023) -
Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells
por: Corno, Cristina, et al.
Publicado: (2020) -
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022) -
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules
por: Costantino, Matteo, et al.
Publicado: (2022)